Atteneri López-Arencibia

11PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChiropracticChemotherapyBiomolecular modelling and designCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 28, 2025
Standardized Artemisia annua Exhibits Dual Antileishmanial Activity and Immunomodulatory Potential In Vitro.

Estefania Morua, Laura Cuyas, Carlos J Bethencourt-Estrella

|Aug 28, 2025
Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound.

Carlos J Bethencourt-Estrella, Atteneri López-Arencibia, Isabel M Calero-Docina

|Feb 26, 2025
Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi.

Carlos J Bethencourt-Estrella, Atteneri López-Arencibia, Jacob Lorenzo-Morales

|Jan 24, 2025
Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model.

Atteneri López-Arencibia, Carlos J Bethencourt-Estrella, Desirée San Nicolás-Hernández

|Sep 27, 2024
E-Cyanoacrylamides and 5-Imino Pyrrolones against Trypanosoma cruzi: Activity and Induced Mechanisms of Cell Death.

Carlos J Bethencourt-Estrella, Samuel Delgado-Hernández, Atteneri López-Arencibia

|Aug 29, 2024
In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment.

Atteneri López-Arencibia, Carlos J Bethencourt-Estrella, Diana Berenguer

Pageof 2